BrokerLens

Curis Lifesciences Limited IPO (CURIS)

Status
Listed
Security type
SME
Price band
RS.120 to RS.128
Final issue price
Rs 128
Issue size
Not disclosed
Bidding opens
7 November 2025
Bidding closes
11 November 2025
Listing date
14 November 2025

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Curis Lifesciences Limited IPO?

The Curis Lifesciences Limited IPO price band is RS.120 to RS.128 per share.

When does the Curis Lifesciences Limited IPO open and close?

Bidding opens 7 November 2025 and closes 11 November 2025.

Is the Curis Lifesciences Limited IPO a mainboard or SME issue?

Curis Lifesciences Limited is an SME IPO, listing on NSE Emerge.

When did the Curis Lifesciences Limited IPO list?

Curis Lifesciences Limited listed on 14 November 2025.

Does this page show the grey market premium (GMP) for Curis Lifesciences Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Curis Lifesciences Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.